STOCK TITAN

SS Innovations CEO buys 100,000 shares for $300K

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

SS Innovations International, Inc. reported that Chairman and Chief Executive Officer Dr. Sudhir Srivastava, through his holding company Sushruta Pvt. Ltd., purchased 100,000 shares of the company’s common stock on November 17, 2026, at $3.00 per share, for an aggregate purchase price of $300,000. The purchase price was paid through an exchange involving $300,000 in accrued but unpaid compensation owed by the company to Dr. Srivastava. The shares were offered and sold under the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933.

Item 3.02 Unregistered Sales of Equity Securities Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Shares purchased 100,000 shares Common stock purchased by Dr. Sudhir Srivastava through Sushruta Pvt. Ltd. on November 17, 2026
Price per share $3.00 per share Purchase of common stock on November 17, 2026
Aggregate purchase price $300,000 Paid through an exchange involving accrued but unpaid compensation owed by the company to Dr. Srivastava
Section 4(a)(2) regulatory
"exemption from registration afforded by Section 4(a)(2)"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
accrued but unpaid compensation financial
"$300,000 owed by the Company to Dr. Srivastava in accrued but unpaid compensation"
unregistered sales of equity securities regulatory
"Unregistered Sales of Equity Securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SSII shares did Dr. Sudhir Srivastava purchase, and at what price?

Dr. Sudhir Srivastava, through his holding company Sushruta Pvt. Ltd., purchased 100,000 shares at $3.00 per share on November 17, 2026, for an aggregate purchase price of $300,000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001676163 0001676163 2026-11-17 2026-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 17, 2026

 

SS INNOVATIONS INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Florida   001-42615   47-3478854
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

405, 3rd Floor, iLabs Info Technology Centre

Udyog Vihar, Phase III

Gurugram, Haryana India

  122016
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +91 73375 53469

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each Class   Trading Symbol   Name of each exchange on which registered
Common Stock   SSII   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

As used in this Current Report on Form 8-K (this ”Current Report”), the terms “SSi,” “the Company,” “we,” “us” and “our” refer to SS Innovations International, Inc. and its subsidiaries.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The disclosure in Item 5.02 of this Current Report below is hereby incorporated by reference in its entirety.

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On November 17, 2026, Dr. Sudhir Srivastava, our Chairman and Chief Executive Officer, through Sushruta Pvt. Ltd., his holding company, purchased 100,000 shares of our common stock for an aggregate purchase price of $300,000 ($3.00 per share). The purchase price was paid by exchanging the Shares for $300,000 owed by the Company to Dr. Srivastava in accrued but unpaid compensation.

 

The shares were offered and sold in accordance with the exemption from registration afforded by Section 4(a)(2) under the Securities Act of 1933, as amended.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 17, 2026 SS INNOVATIONS INTERNATIONAL, INC.
     
  By: /s/ Sudhir Srivastava
    Sudhir Srivastava, M.D.
    Chairman and Chief Executive Officer

 

2

 

Filing Exhibits & Attachments

3 documents

Keep reading